Splenopentin Acetate | CAS:105184-37-0

We serve Splenopentin Acetate CAS:105184-37-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Splenopentin Acetate

Chemical Name:Splenopentin Acetate
CAS.NO:105184-37-0
Synonyms:Splenopentin Acetate
ARG-LYS-GLU-VAL-TYR ACETATE SALT
SPLENOPENTIN ACETATE SALT
ARG-LYS-GLU-VAL-TYR ACETATE
 
Physical and Chemical Properties:
Molecular Formula C33H55N9O11
Molecular Weight 753.84300
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Splenopentin is an immunomodulatory pentapeptide which corresponds to the amino acids 32-36 (Arg-Lys-Glu-Val-Tyr) of the splenic hormone splenin.



Contact us for information like Splenopentin Acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ARG-LYS-GLU-VAL-TYR ACETATE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Splenopentin Acetate Use and application,ARG-LYS-GLU-VAL-TYR ACETATE SALT technical grade,usp/ep/jp grade.


Related News: At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase.2-(p-chlorophenyl)-1-methyl-5-(trifluoromethyl)-2-pyrroline-3-carbonitrile manufacturer This includes chemical APIs.6-fluoro-2-(oxiran-2-yl)-3,4-dihydro-2H-chromene supplier This includes chemical APIs.Tetrahydrothiophen-3-one vendor First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.A key publication in a preclinical model demonstrated rigosertib’s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: “A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.” Cell 165, 643).